ArticleBMC microbiology2026
Retrieving of diguanylate cyclases responsible for biofilm formation and antibiotic resistance in Acinetobacter baumannii.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAs a common opportunistic nosocomial pathogen, Acinetobacter baumannii has emerged as an increasingly multidrug-resistant threat due to its strong biofilm lifestyle. The GGDEF/EAL domain proteins regulate c-di-GMP metabolism, thereby affecting biofilm formation and antibiotic resistance. Nevertheless, the effects of such proteins on biofilm formation and antibiotic resistance of A. baumannii remain unclear.
resultsIn this study, we identified and characterized the GGDEF/EAL domain proteins in A. baumannii and evaluated their contributions to biofilm formation and antibiotic resistance. Comparative genomic analysis revealed eleven genes encoding putative proteins that metabolize c-di-GMP in A. baumannii EMB-1. Overexpression of individual putative proteins showed that a diguanylate cyclase DGC8 markedly influenced the colony morphology, surface-associated motility, and biofilm formation of A. baumannii EMB-1. Furthermore, the antibiotic susceptibility test showed that DGC8 enhances the resistance of EMB-1 to four frequently used antibiotics (i.e., ceftazidime, cefepime, levofloxacin, and tigecycline). Importantly, molecular biology evidence suggests that DGC8 regulates biofilm formation through the Csu pili-mediated pathway.
conclusionsTogether, our findings provide a basis for understanding the physiology of drug resistance in A. baumannii through the regulation of biofilm formation and surface-associated motility, shedding light on targeting DGC8 as an emerging mitigation strategy to control this pathogen.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.